Labeler
Bionpharma Inc. NDC Codes
Bionpharma Inc. lists 183 finished drug products in the FDA NDC Directory under NDC labeler code 69452.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Fluvoxamine maleate, olanzapine, Magnesium Citrate, Allergy Relief, Cimetidine, Prochlorperazine Maleate, Terazosin, divalproex sodium, Dexamethasone, Ropinirole, gas relief, Colesevelam Hydrochloride, Acetaminophen and Ibuprofen, etravirine, Cetirizine Hydrochloride
- Active ingredients
- Diphenhydramine hydrochloride, Ibuprofen, Fluvoxamine maleate, Dimethicone, Olanzapine, Acetaminophen, Magnesium citrate, Cimetidine, Prochlorperazine maleate, Terazosin hydrochloride, Cetirizine hydrochloride, Divalproex sodium
- NDC labeler codes
- 69452
- Strengths (from the 100 most recently listed products)
- Ibuprofen 125 mg/1; Acetaminophen 250 mg/1; Magnesium citrate 1.745 g/29.6mL; Diphenhydramine hydrochloride 50 mg/1; Diphenhydramine hydrochloride 25 mg/1; Colesevelam hydrochloride 625 mg/1; Cetirizine hydrochloride 10 mg/1; Ibuprofen 200 mg/1; Dimethicone 125 mg/1; Diphenhydramine hydrochloride 2 mg/100mL; Fluvoxamine maleate 25 mg/1; Fluvoxamine maleate 100 mg/1; Prochlorperazine maleate 5 mg/1; Prochlorperazine maleate 10 mg/1; Dimethicone 500 mg/1; Pyrantel pamoate 250 mg/1; Docosanol 100 mg/g; Dextromethorphan hydrobromide 15 mg/1; Olanzapine 15 mg/1; Olanzapine 5 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Liquid filled, Capsule, Solution, Liquid, Tablet, Delayed release, Tablet, Orally disintegrating, Cream, Suspension, Gel, Ointment, Tablet, Chewable, Syrup, Patch, Tablet, Extended release
- Routes
- Oral, Topical
- Drug classes (FDA established)
- Histamine-1 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Osmotic Laxative, Calculi Dissolution Agent, Serotonin Reuptake Inhibitor, Atypical Antipsychotic, Histamine-2 Receptor Antagonist, Phenothiazine, Anti-epileptic Agent, Mood Stabilizer, alpha-Adrenergic Blocker, Corticosteroid, Nonergot Dopamine Agonist, Bile Acid Sequestrant, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Anticholinergic, Opioid Agonist, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, P2Y12 Platelet Inhibitor, Antihistamine, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Dihydropyridine Calcium Channel Blocker, Amide Local Anesthetic, Antiarrhythmic, Thyroid Hormone Synthesis Inhibitor, gamma-Aminobutyric Acid A Receptor Agonist, Cholinergic Muscarinic Antagonist, Stimulant Laxative, alpha-Adrenergic Agonist, Biguanide, alpha-1 Adrenergic Agonist, Copper Absorption Inhibitor, Cholinergic Receptor Agonist, Vitamin B6 Analog, Methylxanthine, Bisphosphonate, Cyclooxygenase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 144 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Azithromycin | Azithromycin dihydrate 600 mg/1 | Tablet, Film coatedOral | 69452-173 | 69452-0173-13 | — |
| Rufinamide | Rufinamide 40 mg/mL | SuspensionOral | 69452-223 | 69452-0223-84 | — |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | 69452-233 | 69452-0233-20 | — |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | 69452-234 | 69452-0234-20 | — |
| Naproxen Sodium | Naproxen sodium 220 mg/1 | Capsule, Liquid filledOral | 69452-179 | 69452-0179-22 | — |
| Ibuprofen, Diphenhydramine HCl | Ibuprofen 200 mg/1; Diphenhydramine hydrochloride 25 mg/1 | Capsule, Liquid filledOral | 69452-205 | 69452-0205-0469452-0205-1169452-0205-15+2 more | — |
| Ibuprofen | Ibuprofen 200 mg/1 | Capsule, Liquid filledOral | 69452-212 | 69452-0212-90 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | 69452-159 | 69452-0159-13 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | 69452-160 | 69452-0160-13 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | 69452-161 | 69452-0161-13 | — |
| Calcitriol | Calcitriol .25 ug/1 | Capsule, Liquid filledOral | 69452-207 | 69452-0207-1369452-0207-20 | — |
| Calcitriol | Calcitriol .5 ug/1 | Capsule, Liquid filledOral | 69452-208 | 69452-0208-1369452-0208-20 | — |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | 69452-133 | 69452-0133-17 | — |
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | 69452-131 | 69452-0131-17 | — |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | 69452-132 | 69452-0132-17 | — |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | 69452-117 | 69452-0117-21 | — |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | 69452-118 | 69452-0118-21 | — |
| Nimodipine | Nimodipine 30 mg/1 | Capsule, Liquid filledOral | 69452-209 | 69452-0209-1369452-0209-20 | — |
| Clobazam | Clobazam 2.5 mg/mL | SuspensionOral | 69452-116 | 69452-0116-45 | — |
| Rizatriptan Benzoate | Rizatriptan benzoate 5 mg/1 | Tablet, Orally disintegratingOral | 69452-156 | 69452-0156-73 | — |
| Rizatriptan Benzoate | Rizatriptan benzoate 10 mg/1 | Tablet, Orally disintegratingOral | 69452-157 | 69452-0157-73 | — |
| Omega-3-Acid Ethyl Esteromega-3-acid ethyl esters | Omega-3-acid ethyl esters 900 mg/1 | Capsule, Liquid filledOral | 69452-175 | 69452-0175-1769452-0175-22 | — |
| Ethosuximide | Ethosuximide 250 mg/1 | Capsule, Liquid filledOral | 69452-152 | 69452-0152-20 | — |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | 69452-148 | 69452-0148-20 | — |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | 69452-149 | 69452-0149-20 | — |
| Paricalcitol | Paricalcitol 1 ug/1 | CapsuleOral | 69452-145 | 69452-0145-13 | — |
| Paricalcitol | Paricalcitol 2 ug/1 | CapsuleOral | 69452-146 | 69452-0146-13 | — |
| Paricalcitol | Paricalcitol 4 ug/1 | CapsuleOral | 69452-147 | 69452-0147-13 | — |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | 69452-144 | 69452-0144-2069452-0144-30 | — |
| Amantadine HClamantadine hydrochloride | Amantadine hydrochloride 100 mg/1 | Capsule, Liquid filledOral | 69452-142 | 69452-0142-2069452-0142-30 | — |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | 69452-143 | 69452-0143-2069452-0143-30 | — |
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | 69452-150 | 69452-0150-20 | — |
| Ergocalciferol | Ergocalciferol 1.25 mg/1 | Capsule, Liquid filledOral | 69452-151 | 69452-0151-20 | — |
Bionpharma Inc.: common questions
- What is Bionpharma Inc.'s NDC labeler code?
- 69452. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Bionpharma Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.